DUOKOPT

This brand name is authorized in Austria, Croatia, Cyprus, Finland, Germany, Poland, Romania, Spain.

Active ingredients

The drug DUOKOPT contains a combination of these active pharmaceutical ingredients (APIs):

1	Dorzolamide UNII QZO5366EW7 - DORZOLAMIDE HYDROCHLORIDE
	Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma.
	Read more about Dorzolamide
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	10746203, 10746232, 13835367, 13835373, 15191017, 15191023, 16002656, 16317064, 16317070, 16391221, 16391238, 17294649, 17586369
ES	Centro de información online de medicamentos de la AEMPS	79101
FI	Lääkealan turvallisuus- ja kehittämiskeskus	407274, 568910
HR	Agencija za lijekove i medicinske proizvode	HR-H-620656079
PL	Rejestru Produktów Leczniczych	100338049
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61082001, W61082002, W61082003, W61082004, W61082005, W61082006